Literature DB >> 21900021

Tackling reperfusion injury after cardiopulmonary bypass with tetrahydrobiopterin: new therapeutic potentials for this phenylketonuria drug?

Yanti Octavia, Natascha L Assman, An L Moens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 21900021      PMCID： PMC3241127          DOI： 10.1016/j.ejcts.2011.04.040

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN： 1010-7940            Impact factor:   4.191


× No keyword cloud information.
  5 in total

1.  B-type natriuretic peptide signal peptide circulates in human blood: evaluation as a potential biomarker of cardiac ischemia.

Authors:  Maithri Siriwardena; Torsten Kleffmann; Peter Ruygrok; Vicky A Cameron; Tim G Yandle; M Gary Nicholls; A Mark Richards; Chris J Pemberton
Journal:  Circulation       Date:  2010-07-06       Impact factor: 29.690

2.  Tetrahydrobiopterin improves cardiac and pulmonary function after cardiopulmonary bypass.

Authors:  Gábor Szabó; Leila Seres; Pál Soós; Matthias Gorenflo; Béla Merkely; Ferenc Horkay; Matthias Karck; Tamás Radovits
Journal:  Eur J Cardiothorac Surg       Date:  2011-02-15       Impact factor: 4.191

Review 3.  C-type natriuretic peptide and guanylyl cyclase B receptor.

Authors:  Stephanie Schulz
Journal:  Peptides       Date:  2005-04-15       Impact factor: 3.750

4.  Plasma arteriovenous cGMP difference as a useful indicator of nitrate tolerance in patients with heart failure.

Authors:  T Tsutamoto; M Kinoshita; Y Ohbayashi; A Wada; Y Maeda; T Adachi
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

5.  Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy.

Authors:  An L Moens; Eiki Takimoto; Carlo G Tocchetti; Khalid Chakir; Djahida Bedja; Gianfranco Cormaci; Elizabeth A Ketner; Maulik Majmudar; Kathleen Gabrielson; Marc K Halushka; James B Mitchell; Shyam Biswal; Keith M Channon; Michael S Wolin; Nicholas J Alp; Nazareno Paolocci; Hunter C Champion; David A Kass
Journal:  Circulation       Date:  2008-05-12       Impact factor: 29.690
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.